Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Drivers and Challenges
    3.1 Drivers
           3.1.1 Rising Incidences of Cancer and Cardiovascular Diseases
           3.1.2 Increasing Use of SPECT and PET Scans
           3.1.3 Rising Ageing Population
           3.1.4 Advances in Radiotracers
    3.2 Challenges
           3.2.1 Shut Down of Nuclear Reactors
           3.2.2 Short Half-life of Radiopharmaceuticals
           3.2.3 Production and Quality Control Challenges
           3.2.4 Reimbursement Issues
4. Industry Overview
    4.1 Nuclear Medicine Diagnostics Market
          4.1.1 Diagnostic Radiopharmaceuticals Market
          4.1.2 Nuclear Medicine Equipments Market
    4.2 Nuclear Medicine Therapeutics Market
    4.3 Nuclear Medicine Market by Geography

5. Recent Trends and Developments
    5.1 Nuclear Medicine: Aiding the Growth of Personalized Medicine 
    5.2 Shift from SPECT to PET Systems
    5.3 Hybrid Imaging Propelling Market Growth
    5.4 Efforts Underway to Overcome Molybdenum-99 Shortage
    5.5 Consolidation in the Market
    5.6 Increasing Number of Clinical Trials

6. Competitive Landscape
     6.1 Advanced Accelerator Applications
     6.2 Mallinckrodt
     6.3 Lantheus Medical Imaging
     6.4 IBA
     6.5 Cardinal Health Inc.
     6.6 Nordion Inc.
     6.7 Siemens Healthcare
     6.8 GE Healthcare